Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Genetic Remodeling Transforms E. Coli into Intestinal Pathogen

By BiotechDaily International staff writers
Posted on 09 Mar 2017
Print article
Image: A low-temperature scanning electron micrograph (SEM) of a cluster of E. coli bacteria, magnified 10,000 times (Photo courtesy of the USDA).
Image: A low-temperature scanning electron micrograph (SEM) of a cluster of E. coli bacteria, magnified 10,000 times (Photo courtesy of the USDA).
A team of molecular microbiologists has traced the genetic steps that enable the common bacteria Escherichia coli to transform from a commensal organism into a pathogenic one.

Enteropathogenic Escherichia coli (EPEC), the cause of severe intestinal infection, employ a type III secretion system (T3SS) to inject effector proteins into intestinal epithelial cells. These effectors subvert host cell processes to promote bacterial colonization.

Investigators at the Hebrew University of Jerusalem showed that the T3SS also functioned to sense the host cell and to trigger in response posttranscriptional remodeling of gene expression in the bacteria. They further showed that upon effector injection, the effector-bound chaperone (CesT), which remained in the EPEC cytoplasm, antagonized the posttranscriptional regulator CsrA.

In obtaining these results, the investigators showed that after attaching to the host by means of pili, the bacteria sensed attachment to the human intestinal cells and activated gene expression in response. This was demonstrated by engineering one of these genes to express a protein that stained the expressing bacteria to appear green under the microscope. Under microscopic examination, the investigators observed that only the attached bacteria fluoresced in bright green, whereas non-attached bacteria remained dark.

"The next steps include mapping in detail the genes that change their expression upon attachment, and describing the precise effects of this expression remodeling,” said senior author Dr. Ilan Rosenshine, professor of bacteriology at the Hebrew University of Jerusalem. “Another important issue is testing whether similar regulation is involved in the infection processes of other pathogens."


Print article

Channels

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2017 Globetech Media. All rights reserved.